Eisai Co., Ltd.: Obesity trials
The registry lists 13 Obesity studies with Eisai Co., Ltd. as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 4Phase 2 2Phase 3 4Phase 4 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 YearsTerminatedNCT03338296Phase 4Results posted
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsCompletedNCT02019264Phase 4Results posted
- A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese AdultsCompletedNCT01987427Phase 4Results posted
- BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity ManagementCompletedNCT00603902Phase 3Results posted
- BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes MellitusCompletedNCT00603291Phase 3Results posted
- BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity ManagementCompletedNCT00395135Phase 3Results posted
- A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of AgeCompletedNCT02398669Phase 1
- To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food IntakeCompletedNCT00829140Phase 1
- Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted StateCompletedNCT00828724Phase 1
- Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly SubjectsCompletedNCT00828581Phase 1
- A Comparative Study of KES524 in Patients With Obesity DiseaseCompletedNCT00165685Phase 3
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00116740Phase 2
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00104507Phase 2